Malin Corporation
plc
Results of Extraordinary
General Meeting
Dublin-Ireland, 26 September 2024: Malin Corporation plc (Euronext Growth Dublin:MLC) ("Malin",
the "Company"), a company investing in highly innovative life
sciences companies, today announces that the resolution proposed at
its Extraordinary General Meeting (the "Resolution") held today in
Dublin was passed.
The Resolution sought shareholder
approval for the creation of additional distributable reserves in
the Company by reducing the Company's existing share capital and to
treat the reserves created at such reduction as distributable. The
full text of the Resolution was included in the Notice of
Extraordinary General Meeting of the Company circulated to
shareholders on 27 August 2024 and made available on the Company's
website.
A summary of the voting results is
available on the Company's website www.malinplc.com.
The Company intends to promptly
apply to the Irish High Court for confirmation of the Resolution,
following which, if the High Court so approves, the share capital
reduction as approved by shareholders will become effective (the
"Share Capital Reduction"). The date of the hearing at which the
High Court's confirmation of the Share Capital Reduction will be
sought will be published on the Company's website, once it has been
fixed by the High Court.
As previously announced, once the
Share Capital Reduction is effective, the Company intends to
proceed with a tender offer to return approximately €45 million to
shareholders, which will require separate shareholder approval.
Details of the tender offer will be announced in conjunction with
the publication of a notice of an extraordinary general meeting and
is in anticipated that the tender offer will take place in Q4
2024.
ENDS
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC)
is a company investing in highly innovative life sciences
companies. Its purpose is to create shareholder value through the
application of long-term capital and operational and strategic
expertise to a diverse range of global healthcare businesses. Malin
has a focus on innovative businesses underpinned by exceptional
science and works with its investee companies, providing strategic
and financial support to enable them to reach their value
potential. Malin is headquartered and domiciled in Ireland and
listed on the Euronext Growth Dublin. For more information
visit www.malinplc.com
For
further information please contact:
Malin
Fiona Dunlevy, Executive
Director/Company Secretary
Tel: +353 (0)1 901 5700
cosec@malinplc.com
Davy Corporate Finance (Euronext Growth Listing Sponsor &
Joint Broker)
Brian Garrahy / Daragh
O'Reilly
Tel: +353 1 679 6363
Sodali & Co (Media enquiries)
Eavan Gannon
Tel: +353 87 236
5973
eavan.gannon@sodali.com
